Cargando…
SAT530 Use of Tamoxifen and Cabergoline to Suppress Breast Tissue Uptake of Radioactive Iodine Among Differentiated Thyroid Cancer Patients
Disclosure: A.H. Mohamed: None. M. Basina: None. Background: Radioactive iodine (RAI) has been used in thyroid cancer treatment. Physiologic breast tissue uptake and accumulation of RAI are not desirable due to increased carcinogenesis risk. Case1:31 years old non lactating female diagnosed with sta...
Autores principales: | Mohamed, Abubakr H B, Basina, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554686/ http://dx.doi.org/10.1210/jendso/bvad114.2001 |
Ejemplares similares
-
SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023) -
SAT448 Effects Of Radioactive Iodine Therapy Of Compensated Autonomous Thyroid Nodule After Pharmacological Suppression Of Tsh Secretion
por: Skoczylas, Aleksander, et al.
Publicado: (2023) -
SAT569 Papillary Thyroid Carcinoma With Renal Metastasis Treated With Radioactive Iodine: A Case Report
por: Apa-Ap, Archimedes Almasol, et al.
Publicado: (2023) -
SAT-601 Navigating The Storm: A Case of Thyroid Storm and Recurrent Grave's Disease after Radioactive Iodine Therapy
por: Parikh, Foram, et al.
Publicado: (2019) -
SAT559 Challenges Involved in Managing a Paraplegic Patient with Metastatic Papillary Thyroid Cancer Requiring Radioactive Iodine Therapy
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)